Stocks and InvestingStocks and Investing
Wed, November 20, 2019
Tue, November 19, 2019
Mon, November 18, 2019
Fri, November 15, 2019
Thu, November 14, 2019
Wed, November 13, 2019
Tue, November 12, 2019

Robyn Karnauskas Initiated (BIIB) at Strong Buy and Held Target at $337 on, Nov 12th, 2019


Published on 2024-10-26 18:08:39 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of SunTrust Robinson Humphrey, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $337 on, Nov 12th, 2019.

Robyn has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 3 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $297 on, Wednesday, October 23rd, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $305 on, Wednesday, October 23rd, 2019


These are the ratings of the 7 analyists that currently disagree with Robyn


  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
  • Adnan Butt of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, October 23rd, 2019
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $335 on, Wednesday, October 23rd, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Sell with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $350 on, Wednesday, October 23rd, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Increased Target to $262 on, Wednesday, October 23rd, 2019
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $325 on, Wednesday, October 23rd, 2019